Raptor Pharmaceutical Corp 4
4 · Raptor Pharmaceutical Corp · Filed Sep 11, 2013
Insider Transaction Report
Form 4
Daley Thomas E
Other
Transactions
- Sale
Common Stock
2013-09-09$14.24/sh−5,000$71,214→ 74,906 total - Exercise/Conversion
Common Stock
2013-09-09$2.23/sh+10,000$22,300→ 79,906 total - Sale
Common Stock
2013-09-09$14.33/sh−10,000$143,272→ 69,906 total - Exercise/Conversion
Stock options (right to buy)
2013-09-09−10,000→ 24,969 totalExercise: $2.23From: 2008-03-10Exp: 2017-09-10→ Common Stock (10,000 underlying) - Sale
Common Stock
2013-09-09$14.24/sh−5,000$71,186→ 69,906 total - Sale
Common Stock
2013-09-09$14.24/sh−5,000$71,206→ 79,906 total
Footnotes (8)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 13, 2013.
- [F2]Options were issued pursuant to the Issuers 2006 Equity Incentive Plan. Options vest 6/48ths on March 10, 2008 and 1/48th per month thereafter.
- [F3]This transaction was executed in multiple trades at prices ranging from $14.07 to $14.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $14.10 to $14.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $14.10 to $14.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $14.22 to $14.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]The shares listed as owned in column 9 represents the total shares that remain outstanding for this option grant dated 9/10/2007.
- [F8]Fully vested and exercisable.